Prevalence of and Risk Factors for Paroxysmal Atrial Fibrillation in Patients with Cardiovascular Disease but without diagnosed Atrial Fibrillation
Journal Title: The Journal of Medical Research - Year 2018, Vol 4, Issue 5
Abstract
Background: Atrial fibrillation (AF) is the most prevalent arrhythmia in the clinical practice, and a range of cardiovascular disease (CVD) is associated with the increased risk of AF. While many epidemiological studies identified risk factors for AF in general population, there have been few studies investigating the prevalence of and risk factors for paroxysmal AF (Paf) in patients with CVD. In this study, we examined the prevalence of Paf and attempted to define the risk factors for Paf in patients with CVD but no known history of AF. Study Design and setting: We selected 342 patients who had prior CVD, or were at risk for CVD, but had not been diagnosed with AF. All patients were followed up with specified tests (e.g., blood tests and urinalysis) at our outpatient clinic. To detect Paf in these patients, a 24-hour Holter electrocardiography (ECG) was performed. Results: Paf was detected in 25 patients (7.2 %) in 342 enrolled patients (mean age, 67.0 years; men, 42.2%). Comparison of clinical features showed that patients with Paf were older (p=0.02), had higher serum brain natriuretic peptide (p=0.04) than those without Paf. More patients with Paf had a history of heart failure (HF) (56.0 % vs.15.7%; odds ratio [OR], 6.81; 95% confidential interval [CI] 2.93 to 15.9; p<0.0001) and proteinuria (32.0% vs. 15.1%; OR 2.64;95%CI 1.08 to 6.45; p=0.03) as well as with advancing age (OR 1.03; 95%CI 1.00 to 1.06; p=0.03). Multivariate logistic regression analysis revealed that HF was significantly associated with Paf independently of other comorbidities (OR 5.40; 95%CI 2.07 to 14.1; p=0.0006). Conclusion: Our study using 24- hour Holter ECG readily identified Paf in the patients with CVD but without diagnosed AF. HF was most strongly associated with Paf independently of other risk factors established by prior population-based studies. A history of HF should be considered as a leading risk factor for Paf in clinical practice.
Authors and Affiliations
Katsura Niijima, Masaru Obokata, Masahiko Kurabayashi
Keywords
Related Articles
- EP ID EP531987
- DOI 10.31254/jmr.2018.4502
- Views 131
- Downloads 0
Prevalence of sickle cell disease in newborns in the Yaounde Central Hospital
Introduction: Sickle cell disease (SCD) in Africa is associated with very high incidence and morbidity and mortality rates, especially for children aged 0-5, yet reliable up-to-date information is lacking. Significant re...
Erythrocyte alloimmunization, rhesus and kell phenotypes for women of childbearing age in Yaounde
Erythrocyte alloimmunization has adverse consequences for polytransfused and obstetric for the fetus of an allo immune mother. However, it remains undervalued in our country. To give an estimate, from September to Decemb...
Profile of respiratory diseases of hospitalized patients at the pneumology unit of Jamot Hospital, Yaounde
Background: Respiratory diseases include very diverse conditions, acute or chronic changes, difficult to classify and evaluate. The impact of respiratory disease on global health is important. With smoking, continued exp...
Anti-HIV effect of cervicovaginal secretions
HIV/AIDS is the death cause worldwide for women of reproductive age, affecting 1.5 million pregnancies. The aim from this letter is investigating anti-HIV activity of cervicovaginal fluid.
Chronic elevated liver enzymes with ABCB11 mutation in healthy adult twin males: A case report
We present a diagnostically challenging case of 30-year-old twin males with chronic elevated liver enzymes (GGT) without history of hepato-biliary diseases. Genetic study disclosed mutations in gene ABCB11 and liver hist...